Coherus' cancer biosimilar faces supply squeeze after company's contract manufacturer overextends itself
17th September 2024 Uncategorised 0 Coherus’ cancer biosimilar faces supply squeeze after company’s contract manufacturer overextends itself
fkansteiner
Tue, 09/17/2024 – 14:03
More: Coherus' cancer biosimilar faces supply squeeze after company's contract manufacturer overextends itself
Source: fierce